Literature DB >> 24412326

Incidence of malignant ovarian germ cell tumors (MOGCTs) in Saudi Arabia.

Ahmed Abu-Zaid1, Ahmed Nazer2, Osama Alomar3, Ayman Azzam4, Haya S Al-Eid5, Tusneem Ahmed Elhassan6, Ismail A Al-Badawi7.   

Abstract

Incidence of malignant ovarian germ cell tumors (MOGCTs) in the Saudi Arabian population has not been studied before. Therefore, the primary objective of this study was to define the population-based incidence rates and histopathological types of MOGCTs in the Saudi Arabian population from 1999 to 2008. Our study showed that MOGCTs are a common type of ovarian tumors in the Saudi Arabian population, and the incidence rates and histopathological types are relatively comparable to the international populations with few differences.
Copyright © 2013 King Faisal Specialist Centre & Research Hospital. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Incidence; Malignant ovarian germ cell tumor; Saudi Arabia

Mesh:

Year:  2014        PMID: 24412326     DOI: 10.1016/j.hemonc.2013.12.001

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  3 in total

1.  Immature Teratoma with Embryonal Carcinoma; a Rare Malignant Mixed Germ Cell Tumor in a 13-Year-Old Girl.

Authors:  Shweta Rana; Manmeet Kaur Gill; Shivani Kalhan; Rahul N Satarkar; Ashok Sangwaiya; Pawan Singh
Journal:  Iran J Pathol       Date:  2016

2.  Histopathological patterns of primary malignant ovarian neoplasms in different age groups in Almadinah Almunawwarah region, KSA.

Authors:  Hala M Yousif; Rabab A Mohammed; Hashim M Missawi; Zeinab M Elsawaf; Abdelkader M Albasri
Journal:  J Taibah Univ Med Sci       Date:  2018-12-11

3.  Demographic features, clinical characteristics, and prognostic factors of non-epithelial ovarian tumors at Princess Noorah Oncology Center, National Guard Hospital, Jeddah, Saudi Arabia.

Authors:  Atheel L Balkhy; Eiman R Saleh; Heyam I Jabali; Hatim M Al-Jifree; Ahmad B Alwazzan
Journal:  Saudi Med J       Date:  2022-02       Impact factor: 1.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.